Searchable abstracts of presentations at key conferences in endocrinology

ea0050mte3 | Autonomous cortisol secretion | SFEBES2017

Autonomous cortisol secretion

Inder Warrick

The concept of subclinical hypercortisolism remains controversial in Endocrinology. Preclinical Cushing’s syndrome, subclinical Cushing’s syndrome or subclinical hypercortisolism, recently renamed in the European Society of Endocrinology Adrenal Incidentaloma Guidelines as ‘autonomous cortisol secretion’, is an example where a definition and name has not been universally agreed upon. Previous studies from Italy have used multiple tests of the hypothalamic-p...

ea0050mte3 | Autonomous cortisol secretion | SFEBES2017

Autonomous cortisol secretion

Inder Warrick

The concept of subclinical hypercortisolism remains controversial in Endocrinology. Preclinical Cushing’s syndrome, subclinical Cushing’s syndrome or subclinical hypercortisolism, recently renamed in the European Society of Endocrinology Adrenal Incidentaloma Guidelines as ‘autonomous cortisol secretion’, is an example where a definition and name has not been universally agreed upon. Previous studies from Italy have used multiple tests of the hypothalamic-p...

ea0050p278 | Neuroendocrinology and Pituitary | SFEBES2017

Pituitary function and quality of life in patients taking oral or transdermal opioid analgesics for non-cancer pain

Lamprecht Andrea , Sorbello Jane , Jang Christina , Torpy David , Inder Warrick

Background: Opioid analgesics are commonly used for chronic non-cancer pain but may impair gonadal and adrenal axis function. We measured pituitary function, rates of hormone deficiency, sexual function and quality of life (QoL) in patients on oral or transdermal opioids versus age and sex-matched controls.Methods: Participants with chronic non-malignant pain receiving oral or transdermal opioids for more than six m...

ea0050p278 | Neuroendocrinology and Pituitary | SFEBES2017

Pituitary function and quality of life in patients taking oral or transdermal opioid analgesics for non-cancer pain

Lamprecht Andrea , Sorbello Jane , Jang Christina , Torpy David , Inder Warrick

Background: Opioid analgesics are commonly used for chronic non-cancer pain but may impair gonadal and adrenal axis function. We measured pituitary function, rates of hormone deficiency, sexual function and quality of life (QoL) in patients on oral or transdermal opioids versus age and sex-matched controls.Methods: Participants with chronic non-malignant pain receiving oral or transdermal opioids for more than six m...

ea0065p275 | Neuroendocrinology | SFEBES2019

Predictive power of ACTH and cortisol in the early post-operative period following pituitary surgery: relationship to long term glucocorticoid requirement

English Katherine , Chikani Viral , Jang Christina , Dimeski Goce , Olson Sarah , Inder Warrick

Hypothalamic–pituitary–adrenal (HPA) axis function after trans-sphenoidal pituitary surgery is commonly assessed using post-operative morning cortisol. We performed a prospective study to determine the sensitivity and specificity of cortisol and ACTH measured within the first 24 h, in predicting glucocorticoid requirement at 6 months both in patients with pre-operative secondary adrenal insufficiency (SAI) and with normal pituitary function. Exclusion criteria includ...

ea0070aep47 | Adrenal and Cardiovascular Endocrinology | ECE2020

Relationship between the hypothalmic-pituitary-adrenocortical axis activity and the characteristics of aldosterone-producing adenomas

Thuzar Moe , Lo Yu-Chin , Guo Zeng , Inder Warrick J , Stowasser Michael

Objective: Aldosterone production can be regulated by adrenocorticotrophic hormone (ACTH) which normally controls cortisol secretion. Some cases of aldosterone-producing adenoma (APA) display features which may suggest increased sensitivity to the stimulatory effects of ACTH. The aim of this study was to investigate if there is any relationship between the hypothalamic--pituitary-adrenocortical (HPA) axis activity and the characteristics of APAs.Methods:...

ea0070aep673 | Pituitary and Neuroendocrinology | ECE2020

Development of a local reference range for hypertonic saline-stimulated copeptin

Brooks Emily , Bachmeier Caroline , Vorster Juanita , Sorbello Jane , Peer Faseeha , Chikani Viral , Dimeski Goce , Ungerer Jacobus , Pretorius Carel , Inder Warrick J

Hypertonic saline stimulated copeptin measurements have recently been described for the diagnosis of central DI. A copeptin cut-off of > 4.9 pmol/l has a diagnostic accuracy of 96.5% for distinguishing primary polydipsia from central DI1. A copeptin assay has recently been established in our laboratory. Validation of hypertonic saline-stimulated copeptin concentrations in our local population is needed before this test can be used with confidence in patients pre...